NCT03863041View on ClinicalTrials.gov

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Memory ComplaintAlzheimer DiseasePhosphorylated Metabolism ProfileMagnetic Resonance Spectroscopy
Interventions
OTHER

Additional sequence performed during MRI scan

An additional sequence will be performed during the MRI scan.

Trial Locations (1)

Unknown

CHU of Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03863041 - Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint. | Biotech Hunter | Biotech Hunter